Matches in Nanopublications for { ?s ?p "[The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP724101.RAArspwfOw_12TnGlr5I5WQMHalQuQGKymoky_ZHlbqbE130_assertion description "[The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724101.RAArspwfOw_12TnGlr5I5WQMHalQuQGKymoky_ZHlbqbE130_provenance.
- assertion description "[The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion description "[The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.